Fundz

Everest Medicines Appoints Sandra Zeng as Chief Medical Officer and Rico Liang as Chief Product Officer

Mar 18, 2024

Position

Chief Product Officer

Company

Everest Medicines

Rico Liang
ManufacturingBiotechnologyHealth CarePharmaceuticalBiopharma

Description

Everest Medicines strengthens its management team with the appointments of Ms. Sandra Zeng as Chief Medical Officer and Mr. Rico Liang as Chief Product Officer

Quick answer

Everest Medicines Appoints Sandra Zeng as Chief Medical Officer and Rico Liang as Chief Product Officer (March 18, 2024).

Who is the new Chief Product Officer at Everest Medicines?
Everest Medicines named Rico Liang Chief Product Officer, announced March 18, 2024.
What did Everest Medicines announce on March 18, 2024?
Everest Medicines strengthens its management team with the appointments of Ms. Sandra Zeng as Chief Medical Officer and Mr. Rico Liang as Chief Product Officer
What does Everest Medicines do?
Everest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address critical unmet medical needs for...
Which similar companies made leadership changes around the same time?
Jazz Pharmaceuticals plc (February 21, 2024), AbbVie Inc. (February 20, 2024), YS Biopharma (February 14, 2024) and Oragenics (March 18, 2024) also announced leadership changes within 45 days of Everest Medicines.

Source: Fundz verified event record.

Other recent leadership changes in Pharmaceutical and Biopharma

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Everest Medicines, and when

A new leader at Everest Medicines brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Everest Medicines raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Everest Medicines, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Everest Medicines. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Everest Medicines

About

Everest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address critical unmet medical needs for patients in Asian markets.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Everest Medicines changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Ge
Likely contact at this company
••••••••@••••••••

See Ge's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Everest Medicines's next move

Learn about Strategic plan

Everest Medicines changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.